Business
The Company is a U.S. manufacturer that has received global regulatory approvals for its product portfolio, which is currently being commercialized in the U.S. and key international markets.
FEMASYS INC: Revenue grew 40.8% to $2.293M from $1.629M. Net loss narrowed to $18.63M from $18.82M. Free cash flow outflow narrowed to $19.22M from $20.21M. Operating margin expanded 32480 bps to -766.95%. FEMASYS INC's annual comparison also shows stock compensation grew faster than revenue; inventory grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context; the earnings-quality screen is grey.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 40.8% to $2.293M from $1.629MOK
- Profitability — Net loss narrowed to $18.63M from $18.82MOK
- Cash flow — Free cash flow outflow narrowed to $19.22M from $20.21MOK
- Margins — Operating margin expanded 32480 bps to -766.95%OK
- Accounting — Going-concern warningWatch
- Insiders — 0 purchases and 0 salesNote
Where the revenue comes from
Fiscal 2025, as FEMASYS INC reports it. History and quarterly detail are in the app.
- Business$2.3M
Leadership changes
From FEMASYS INC's own filings, the day they're filed.
- Kenneth D. Eichenbaum · director · appointmenteff. 2026-03-18
- Joshua Silverman · Directors · departureeff. 2026-03-17
- Daniel Currie · Chief Operating Officer · departureeff. 2025-12-15
Latest filings
- 8-K · Company announcement2026-08-14
- 10-Q · Quarterly report2026-08-14
- 8-K · Company announcement2026-08-11
- 8-K · Company announcement2026-06-24
- 8-K · Company announcement2026-06-24
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about FEMASYS INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.